Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

CervoMed (CRVO) EBT Margin (2023 - 2025)

Historic EBT Margin for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to 2394.96%.

  • CervoMed's EBT Margin fell 21500800.0% to 2394.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 415.21%, marking a year-over-year decrease of 2965700.0%. This contributed to the annual value of 167.28% for FY2024, which is 610000.0% down from last year.
  • Latest data reveals that CervoMed reported EBT Margin of 2394.96% as of Q3 2025, which was down 21500800.0% from 355.47% recorded in Q2 2025.
  • In the past 5 years, CervoMed's EBT Margin ranged from a high of 70.44% in Q2 2024 and a low of 2394.96% during Q3 2025
  • Moreover, its 3-year median value for EBT Margin was 172.13% (2023), whereas its average is 379.52%.
  • In the last 5 years, CervoMed's EBT Margin surged by 1100bps in 2024 and then crashed by -21500800bps in 2025.
  • CervoMed's EBT Margin (Quarter) stood at 94.83% in 2023, then tumbled by -227bps to 310.3% in 2024, then tumbled by -672bps to 2394.96% in 2025.
  • Its EBT Margin stands at 2394.96% for Q3 2025, versus 355.47% for Q2 2025 and 255.22% for Q1 2025.